The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can significantly improve symptoms.

Biohaven announced topline results from its pivotal Study BHV4157-206-RWE, showing that troriluzole significantly slowed ...

Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).

Biohaven's drug for a genetic disease that affects the nervous system met the main study goal, sending its shares up more ...

Researchers from Stanford University and Rensselaer Polytechnic Institute have developed an advanced AI model that improves ...

FDA confirms that SciSparc’s study may proceed following the application submission a month agoTEL AVIV, Israel, Sept. 23, 2024 (GLOBE ...

Pharmaceutical company SciSparc Ltd. (SPRC) announced Monday that the U.S. Food and Drug Administration (FDA) has confirmed that its ...

With the initiation of PALISADE-4 as planned, we have achieved another important milestone in our registration-directed PALISADE Phase 3 program for fasedienol, which has potential to deliver a ...

Investors and analysts predict the FDA will approve Applied Therapeutics' lead candidate govorestat for classic galactosemia ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that the U.S Food and Drug Administration (FDA) has cleared its investigational new drug (IND) ...

As the FDA prepares to render a verdict on BMS’ closely watched schizophrenia drug, BioSpace takes a closer look at the ...

Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more effective treatments. One organ receiving particular attention in this area is ...